Stereotaxis, Medtronic to study magnetic navigation in cardiac implants

By Elaine Rigoli

Tampa, Fla., May 18 - Stereotaxis, Inc. and Medtronic, Inc. will co-sponsor a post-market, prospective, randomized outcomes-based clinical study to determine the role of magnetic navigation in LV lead placement optimization.

The study will pair magnetically guided LV lead implant techniques with select physiological parameters to measure response to pacing in multiple sites within the coronary venous system to determine the best pacing location, according to a news release.

This optimized LV lead implant will be compared with conventional lead implant techniques to determine the difference in chronic response to optimized LV lead implant vs. conventional LV lead implants, the release said.

The study is expected to begin enrollment in the second half of this year.

St. Louis-based Stereotaxis designs cardiology instrument control systems.

Medtronic is a medical technology company located in Minneapolis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.